US based Aridis Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel ant...
Glenmark Pharmaceuticals has announced the approval from the Ministry of Healthcare, Russia to market Montlezir (Levocet...
Kiran Mazumdar-Shaw, CMD, Biocon has promised to enable universal access to rh-Insulin by reducing prices to less than 1...
The Vice President of India, M. Venkaiah Naidu has called for making India a thriving hub for natural healing and wellne...
3M India, a subsidiary of leading global innovation company has signed a MoU with Infusion Nurses Society (INS-Ind)...
Asia’s premier biopharmaceuticals company, has announced that its subsidiary, Biocon Biologics, has acquired R&...
Strides Pharma Science Limited,a global pharmaceutical company headquartered in Bangalore, India, has announced that the...
Eisai Co., Ltd. has announced that Eisai’s subsidiary Eisai Pharmaceuticals India Pvt. Ltd. and Mylan N. V. subsid...
Glenmark Pharmaceuticals has announced that the USFDA has granted Orphan Drug Designation to its bispecific antibody can...
Can you throw some light on your recent expansion in Delhi-NCR? mfine is an AI powered, on-demand healthcare platform ...
Zebra Medical Vision, the deep learning medical imaging analytics company, has announced its partnership with Medsy...
Biocon Ltd, Asia’s premier biopharmaceuticals company, has announced that it has signed a License and Supply Agree...
Nobel laureates and world-leading experts will meet in Delhi and Punjab India, to address the topic of “Teaching a...
The Board of Directors of Sanofi India Limited (SIL) has approved a transaction for the slump sale and transfe...
Indian Pharma major Lupin Limited (Lupin) on 9 Sep 2019, announced that it has received approval for its Ethacrynic Acid...
Boehringer Ingelheim and Lupin Limited (Lupin) has announced a licensing, development and commercialization agreement fo...
GVK BIO, a leading global Contract Research and Development Organisation (CRDO), has announced the promotion of Sudhir K...
Biocon said that the US Food and Drug Administration (US FDA) has issued a complete response letter (CRL) for the New Dr...
